Smartphone-delivered Therapeutic Evaluative Conditioning for suicidal thoughts and behavior
Official title: A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
Run by Massachusetts General Hospital · NCT06967545 · Data updated 2026-11-12
This study will test whether a smartphone program called Therapeutic Evaluative Conditioning (TEC-S) can reduce suicidal thoughts and behaviors in adults who have had frequent recent suicide ideation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | January 20, 2026 |
| Main results expected | October 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT06967545 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older who live in the Boston metropolitan area, have experienced frequent recent suicidal ideation (about ≥5 days in the past month), own an iOS or Android smartphone, and can provide informed consent and an emergency contact are the ideal candidates.
✕Probably not a fit
People with recent hypo/manic symptoms, recent homicidal ideation, a lifetime psychosis-spectrum diagnosis, those judged to be at acute imminent suicide risk, or individuals living outside the Boston area or without a smartphone are unlikely to be eligible or to benefit from this pilot.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This one-arm open trial will enroll 20 adults in the greater-Boston area who report recent and frequent suicidal thoughts or behaviors. Participants will complete ecological momentary assessments (EMA) three times daily and will have optional access to the smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S) intervention. The intervention uses classical evaluative conditioning delivered via phone to try to change attitudes toward suicide, and weekly behavioral and self-report measures will track hypothesized mechanisms and outcomes. The primary aims are to test safety, acceptability, and preliminary efficacy of TEC-S in reducing suicidal thoughts and behaviors.
Why it matters
Potential benefit: If successful, TEC-S could provide a low-burden, widely accessible smartphone option to help reduce suicidal thoughts and behaviors by changing attitudes toward suicide.
How similar studies have gone: Similar smartphone- and EMA-based interventions for suicidal ideation have shown mixed but promising early results, while TEC-S specifically—applying evaluative conditioning to suicide-related attitudes—is relatively novel and largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ages 18+ * Relatively frequent and recent (≥5 days within the past-month) active suicidal thoughts as assessed via SITBI-R. * Willing and able to provide at least one emergency contact (name, phone number, relation). * Owns an Android or iOS smartphone. * Possesses at least occasional access to Wi-Fi-enabled internet for data down/uploads. * Fluent in English and willing to provide informed consent. * Living in the Boston metropolitan area (i.e., \~50 mile radius around Boston, MA) Exclusion Criteria: * Recent (past 3-month) hypo/manic symptoms or homicidal ideation or lifetime psychosis spectrum diagnosis as assessed via MINI 7.0.2. * Recent acute suicide risk operationalized as affirmative responses to BOTH below items during structured clinical interview AND evaluation by the PI in consultation with Mentors/Advisor Drs. Wilhelm, Kleiman, and/or Bentley: * At any time in past week: ≥ 8/10 current intent to act on suicidal thoughts (0 \["not at all"\] to 10 \["extremely strong"\]); AND * At any time in past week: thought of a specific suicide plan (i.e, known method/means and/or location) with access to lethal means * Impaired vision (e.g., legal blindness), technological illiteracy, or intellectual disability that might impair ability to provide valid data and/or informed consent.
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Adam C Jaroszewski, PhD
- Email: ajaroszewski@mgh.harvard.edu
- Phone: 781-258-3082
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Plan & Protect safety planning for teens in rural EDs
A tablet-based safety planning program is being tested in rural emergency departments to see if it helps families make homes safer and lowers suicide risk for 12-17 year olds.
-
Using a smartphone app to help prevent suicide in veterans after hospital discharge
This study is testing a smartphone app designed to help prevent suicide in veterans after they leave the hospital by providing support and resources to manage their mental health.
-
Caring Connections: youth suicide detection and support
This pilot will test whether Caring Connections, a culturally adapted 90-day care coordination program delivered through community and faith-based hubs, helps high-risk Black and other youth aged 13–19 reduce suicidal thoughts and connect with mental health services.
-
Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk
This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.
-
New Generation Therapies for Suicide: Refining Brief Cognitive Behavioral Therapy
This study tests different sequences and doses of Brief Cognitive Behavioral Therapy to see if it better reduces suicide risk in adults with recent suicidal thoughts or behavior.
-
Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts in Swedish Psychiatric Inpatient Care
This study tests whether four brief CBT sessions can be delivered during a psychiatric hospital stay to help adults who recently attempted suicide or are at high risk see if the treatment works and is easy to use in routine care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.